Association of screening status, polygenic risk score and environmental risk factors with colorectal cancer incidence and mortality risks

被引:2
|
作者
Ren, Jiaojiao [1 ,2 ]
Zhang, Peidong [2 ,3 ]
Li, Zhihao [2 ]
Zhang, Xiru [2 ]
Shen, Dong [2 ]
Chen, Peiliang [2 ]
Huang, Qingmei [2 ]
Gao, Pingming [1 ,4 ]
Mao, Chen [2 ,5 ]
机构
[1] Southern Med Univ, Affiliated Foshan Matern & Child Healthcare Hosp, Foshan, Guangdong, Peoples R China
[2] Southern Med Univ, Sch Publ Hlth, Dept Epidemiol, Guangzhou, Guangdong, Peoples R China
[3] Southern Med Univ, Nanfang Hosp, Dept Neurosurg, Guangzhou, Guangdong, Peoples R China
[4] Southern Med Univ, Sch Clin Med 2, Guangzhou, Guangdong, Peoples R China
[5] Southern Med Univ, Zhujiang Hosp, Microbiome Med Ctr, Dept Lab Med, Guangzhou, Guangdong, Peoples R China
基金
中国国家自然科学基金; 中国博士后科学基金;
关键词
colorectal cancer; environmental risk factors; polygenic risk score; screening; HEALTHY LIFE-STYLE;
D O I
10.1002/ijc.34407
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Whether screening can attenuate the influence of genetic risk and environmental risk factors for colorectal cancer (CRC) mortality risk remains unknown. Our study is to investigate the association of the screening history, genetic risk and environmental risk factors with CRC incidence and mortality risks using UK Biobank data. Screening history was associated with lower CRC incidence (hazard ratio [HR]: 0.63, 95% confidence interval [CI]: 0.58-0.69) and mortality risk (HR: 0.56, 95% CI: 0.49-0.63). Compared to the HRs of participants with a low genetic risk, low environmental risk and no screening history, the HRs of participants with a high genetic risk, high environmental risk and no screening history were 3.42 (95% CI: 2.76-4.24) for CRC incidence and 3.36 (95% CI: 2.48-4.56) for CRC mortality. In contrast, the HRs of participants with a high genetic risk and no screening history, but a low environmental risk, were 1.92 (95% CI: 1.55-2.36) for CRC incidence and 1.88 (95% CI: 1.39-2.53) for CRC mortality. Furthermore, the HRs of participants with a high genetic risk and a low environmental risk, but a screening history were 1.62 (95% CI: 1.15-2.28) for CRC incidence and 1.77 (95% CI: 1.08-2.89) for CRC mortality. Participants benefited more substantially from screenings for CRC mortality than for CRC incidence risk. A higher environmental risk was associated with higher risk of CRC incidence and mortality within each category of genetic risk. These findings emphasize the importance of CRC screening and identifying environmental factors to reduce CRC incidence and mortality risks.
引用
收藏
页码:1778 / 1788
页数:11
相关论文
共 50 条
  • [1] Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium
    Rudolph, Anja
    Song, Minsun
    Brook, Mark N.
    Milne, Roger L.
    Mavaddat, Nasim
    Michailidou, Kyriaki
    Bolla, Manjeet K.
    Wang, Qin
    Dennis, Joe
    Wilcox, Amber N.
    Hopper, John L.
    Southey, Melissa C.
    Keeman, Renske
    Fasching, Peter A.
    Beckmann, Matthias W.
    Gago-Dominguez, Manuela
    Castelao, Jose E.
    Guenel, Pascal
    Truong, Therese
    Bojesen, Stig E.
    Flyger, Henrik
    Brenner, Hermann
    Arndt, Volker
    Brauch, Hiltrud
    Bruening, Thomas
    Mannermaa, Arto
    Kosma, Veli-Matti
    Lambrechts, Diether
    Keupers, Machteld
    Couch, Fergus J.
    Vachon, Celine
    Giles, Graham G.
    MacInnis, Robert J.
    Figueroa, Jonine
    Brinton, Louise
    Czene, Kamila
    Brand, Judith S.
    Gabrielson, Marike
    Humphreys, Keith
    Cox, Angela
    Cross, Simon S.
    Dunning, Alison M.
    Orr, Nick
    Swerdlow, Anthony
    Hall, Per
    Pharoah, Paul D. P.
    Schmidt, Marjanka K.
    Easton, Douglas F.
    Chatterjee, Nilanjan
    Chang-Claude, Jenny
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2018, 47 (02) : 526 - 536
  • [2] Relationship between polygenic risk score, lifestyle factors, and colorectal cancer risk
    Huang, Wen-Yi
    Loftfield, Erikka
    Landy, Rebecca
    Wang, Difei
    Katki, Hormuzd A.
    Shi, Jianxin
    Wang, Lingxiao
    Machiela, Mitchell J.
    Freedman, Neal D.
    Berndt, Sonja I.
    CANCER RESEARCH, 2024, 84 (06)
  • [3] Evaluating the Potential of Polygenic Risk Score to Improve Colorectal Cancer Screening
    Arnau-Collell, Coral
    Diez-Villanueva, Anna
    Bellosillo, Beatriz
    Auge, Josep M.
    Munoz, Jenifer
    Guino, Elisabe
    Moreira, Leticia
    Serradesanferm, Anna
    Tora-Rocamora, Isabel
    Bonjoch, Laia
    Ibanez-Sanz, Gemma
    Obon-Santacana, Mireia
    Moratalla-Navarro, Ferran
    Sanz-Pamplona, Rebeca
    Marquez, Carmen Marquez
    Miret, Rebeca Rueda
    Berbegal, Rocio Perez
    Velasco, Gabriel Piquer
    Rodriguez, Cristina Hernandez
    CRIPREV Consortium, Antoni
    Grau, Jaume
    Castells, Antoni
    Borras, Josep M.
    Bessa, Xavier
    Moreno, Victor
    Castellvi-Bel, Sergi
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2022, 31 (07) : 1305 - 1312
  • [4] Evaluating the potential of polygenic risk score to improve colorectal cancer screening
    Arnau-Collell, Coral
    Diez-Villanueva, Ana
    Bellosillo, Beatriz
    Auge, Josep M.
    Munoz, Jenifer
    Guino, Elisabet
    Moreira, Leticia
    Serradesanferm, Anna
    Pozo, Angels
    Tora, Isabel
    Bonjoch, Laia
    Ibanez-Sanz, Gemma
    Obon-Santacana, Mireia
    Moratalla-Navarro, Ferran
    Sanz-Pamplona, Rebeca
    Marquez Marquez, Carmen
    Rueda Miret, Rebeca
    Perez Berbegal, Rocio
    Piquer Velasco, Gabriel
    Hernandez Rodriguez, Cristina
    Grau, Jaume
    Castells, Antoni
    Borras, Josep M.
    Bessa, Xavier
    Moreno, Victor
    Castellvi-Bel, Sergi
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2023, 31 : 531 - 531
  • [5] Association of polygenic risk score and menopausal hormone therapy for colorectal cancer risk.
    Tian, Yu
    Lin, Yi
    Kim, Andre E.
    Bien, Stephanie A.
    Newcomb, Polly A.
    Casey, Graham
    Platz, Elizabeth A.
    Le Marchand, Loic
    Campbell, Peter T.
    Brenner, Hermann
    Hoffmeister, Michael
    Guo, Feng
    Chen, Xuechen
    Gunter, Marc J.
    Dimou, Niki
    Gruber, Stephen B.
    Chan, Andrew T.
    Joshi, Amit D.
    Berndt, Sonja I.
    White, Emily
    Moreno, Victor
    Prentice, Ross L.
    Peters, Ulrike
    Gauderman, William
    Hsu, Li
    Chang-Claude, Jenny
    CANCER RESEARCH, 2021, 81 (13)
  • [6] Combined association of a polygenic risk score with 313 genetic variants and established environmental risk factors in relation to breast cancer risk
    Middha, Pooja
    Mavaddat, Nasim
    Milne, Roger L.
    Simard, Jacques
    Schmidt, Marjanka K.
    Kraft, Peter
    Pharoah, Paul D. P.
    Easton, Douglas F.
    Garcia-Closas, Montserrat
    Chang-Claude, Jenny
    GENETIC EPIDEMIOLOGY, 2018, 42 (07) : 716 - 716
  • [7] Physical activity, polygenic risk score, and colorectal cancer risk
    Chen, Xuechen
    Guo, Feng
    Chang-Claude, Jenny
    Hoffmeister, Michael
    Brenner, Hermann
    CANCER MEDICINE, 2023, 12 (04): : 4655 - 4666
  • [8] Association of a polygenic risk score with risk of abnormal ultrasound findings and ovarian cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
    Phillips, Sarah
    Landy, Rebecca
    Bodelon, Clara
    Machiela, Mitchell J.
    Temkin, Sarah M.
    Wentzensen, Nicolas
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [9] Implications of Lifestyle Factors and Polygenic Risk Score for Absolute Risk Prediction of Colorectal Neoplasm and Risk-Adapted Screening
    Chen, Hongda
    Liu, Li
    Lu, Ming
    Zhang, Yuhan
    Lu, Bin
    Zhu, Ying
    Tian, Jianbo
    Li, Xinying
    Nie, Shaofa
    Miao, Xiaoping
    Dai, Min
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 8
  • [10] Polygenic risk scores to stratify cancer screening should predict mortality not incidence
    Vickers, Andrew J.
    Sud, Amit
    Bernstein, Jonine
    Houlston, Richard
    NPJ PRECISION ONCOLOGY, 2022, 6 (01)